For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...
Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.
ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control, and adding savory flavors are ways that ...
ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control and adding savory flavors are ways that ...
Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...
Northstrive Biosciences has submitted a pre-Investigational New Drug, or pre-IND, meeting request to the FDA for EL-22, a novel myostatin asset ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Is Hims & Hers a millionaire-maker in the making? Yes! Or, at least, it can be. There is a possible future where Hims & Hers ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results